We propose that the inhibition of FGFR4 signaling through KLB-silencing in HCC cells eliminated the hyper-proliferative FGFR4-overexpressing cell population, while enriching for resistant cells with progenitor features. This evidence concerns the gene KLB and hepatocellular carcinoma.